Table 2.

Multivariate Analysis of Association Between Participant Characteristics and Physical Health (Baseline)

	Model 1 adjusted OR [95% CI]	Model 2 adjusted OR [95% CI]
Log-transformed estradiol	1.16 [1.01–1.35]	1.03 [0.88–1.20]
Age at diagnosis
<50 (Reference)
50–59	1.00 [0.73–1.37]	0.88 [0.64–1.22]
60–-69	1.37 [0.93–2.00]	1.17 [0.79–1.73]
70–74	1.97 [0.35–11.01]	2.22 [0.40–12.31]
Cancer stage (Reference I)
II	1.24 [0.89–1.73]	1.24 [0.87–1.75]
III	1.67 [1.11–2.50]	1.64 [1.08–2.44]
Tamoxifen (current use vs. no use)	0.80 [0.61–1.05]	0.86 [0.65–1.13]
Chemotherapy (prior chemotherapy vs. none)	1.20 [0.84–1.72]	1.01 [0.69–1.46]
Years diagnosis to study entry	0.79 [0.69–0.90]	0.76 [0.67–0.87]
Alcohol consumption (>1g/day vs.<1g/day)	0.63 [0.49–0.83]	0.70 [0.53–0.92]
Physical activity	0.51 [0.39–0.67]	0.59 [0.45–0.77]
BMI (Reference <25) Overweight	–	1.38 [1.00–1.90]
Obese	–	2.59 [1.83–3.67]

BMI, body mass index.